Go to Sygnis Pharma AG Homepage  

SYGNIS Pharma AG

Becoming a DNA products company

Latest Company News

• 2015/05/16 : SYGNIS licenses amplification buffer to QIAGEN (Press Release)

• 2015/05/15 : SYGNIS reports results for the first quarter of 2013 (Press Release)

• 2013/04/30 : SYGNIS reports financial results for fiscal year 2012 (Press Release)

• 2013/04/23 : SYGNIS granted US patent for QUALIPHI®, the Next Generation DNA amplification tool (Press Release)

• 2013/03/25 : SYGNIS announces Management Board changes (Ad hoc)

• 2013/03/04 : SYGNIS Pharma AG secures further financial resources with shareholder loan (Ad hoc)

• 2013/01/15 : SYGNIS is granted the European and US patent for a very versatile and efficient drug screening platform (Press Release)

Upcoming Events

• 7 January 2013 - J.P. Morgan Annual Healthcare Conference, San Francisco